Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
Soon after they were first described in 1990, aptamers were largely recognized as a new class of biological ligands that can rival antibodies in various analytical, diagnostic, and therapeutic applications. Aptamers are short single-stranded RNA or DNA oligonucleotides capable of folding into complex 3D structures, enabling them to bind to a large variety of targets ranging from small ions to an entire organism. Their high binding specificity and affinity make them comparable to antibodies, but they are superior regarding a longer shelf life, simple production and chemical modification, in addition to low toxicity and immunogenicity. In the past three decades, aptamers have been used in a plethora of therapeutics and drug delivery systems that involve innovative delivery mechanisms and carrying various types of drug cargos. However, the successful translation of aptamer research from bench to bedside has been challenged by several limitations that slow down the realization of promising aptamer applications as therapeutics at the clinical level. The main limitations include the susceptibility to degradation by nucleases, fast renal clearance, low thermal stability, and the limited functional group diversity. The solution to overcome such limitations lies in the chemistry of aptamers. The current review will focus on the recent arts of aptamer chemistry that have been evolved to refine the pharmacological properties of aptamers. Moreover, this review will analyze the advantages and disadvantages of such chemical modifications and how they impact the pharmacological properties of aptamers. Finally, this review will summarize the conjugation strategies of aptamers to nanocarriers for developing targeted drug delivery systems.
Top-30
Citations by journals
2
4
6
8
10
12
14
16
18
|
|
International Journal of Molecular Sciences
17 publications, 7.3%
|
|
Pharmaceutics
7 publications, 3%
|
|
Molecules
6 publications, 2.58%
|
|
Frontiers in Pharmacology
4 publications, 1.72%
|
|
Biomedicines
4 publications, 1.72%
|
|
Biosensors
4 publications, 1.72%
|
|
Nucleic Acid Therapeutics
3 publications, 1.29%
|
|
Frontiers in Cell and Developmental Biology
3 publications, 1.29%
|
|
Chemosensors
3 publications, 1.29%
|
|
Sensors
3 publications, 1.29%
|
|
Molecular Therapy - Nucleic Acids
3 publications, 1.29%
|
|
Analytica Chimica Acta
3 publications, 1.29%
|
|
Talanta
3 publications, 1.29%
|
|
Biosensors and Bioelectronics
3 publications, 1.29%
|
|
Bioconjugate Chemistry
3 publications, 1.29%
|
|
Methods in Molecular Biology
3 publications, 1.29%
|
|
Microchimica Acta
3 publications, 1.29%
|
|
Expert Opinion on Drug Delivery
3 publications, 1.29%
|
|
Analytical Chemistry
2 publications, 0.86%
|
|
Diagnostics
2 publications, 0.86%
|
|
Micromachines
2 publications, 0.86%
|
|
Frontiers in Bioengineering and Biotechnology
2 publications, 0.86%
|
|
World Journal of Microbiology and Biotechnology
2 publications, 0.86%
|
|
Analytical and Bioanalytical Chemistry
2 publications, 0.86%
|
|
Molecular Biotechnology
2 publications, 0.86%
|
|
Environmental Research
2 publications, 0.86%
|
|
Molecular Therapy
2 publications, 0.86%
|
|
European Journal of Pharmacology
2 publications, 0.86%
|
|
Bioengineering & Translational Medicine
2 publications, 0.86%
|
|
2
4
6
8
10
12
14
16
18
|
Citations by publishers
10
20
30
40
50
60
70
|
|
Elsevier
64 publications, 27.47%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
60 publications, 25.75%
|
|
Springer Nature
20 publications, 8.58%
|
|
Wiley
16 publications, 6.87%
|
|
American Chemical Society (ACS)
12 publications, 5.15%
|
|
Frontiers Media S.A.
11 publications, 4.72%
|
|
Taylor & Francis
8 publications, 3.43%
|
|
Royal Society of Chemistry (RSC)
7 publications, 3%
|
|
Bentham Science
4 publications, 1.72%
|
|
Mary Ann Liebert
3 publications, 1.29%
|
|
Pleiades Publishing
2 publications, 0.86%
|
|
Open Exploration Publishing
2 publications, 0.86%
|
|
Future Medicine
2 publications, 0.86%
|
|
Beilstein-Institut
1 publication, 0.43%
|
|
American Institute of Physics (AIP)
1 publication, 0.43%
|
|
SAGE
1 publication, 0.43%
|
|
King Saud University
1 publication, 0.43%
|
|
KeAi Communications Co.
1 publication, 0.43%
|
|
Cairo University
1 publication, 0.43%
|
|
Cold Spring Harbor Laboratory
1 publication, 0.43%
|
|
Walter de Gruyter
1 publication, 0.43%
|
|
Public Library of Science (PLoS)
1 publication, 0.43%
|
|
All-Russian Institute of Plant Protection
1 publication, 0.43%
|
|
Research Square Platform LLC
1 publication, 0.43%
|
|
Moscow University Press
1 publication, 0.43%
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.43%
|
|
The University of Jordan
1 publication, 0.43%
|
|
Allerton Press
1 publication, 0.43%
|
|
Oxford University Press
1 publication, 0.43%
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.